U.S. FDA· FDA·· 4 hours agoPickScore57
Commissioner's National Priority Voucher (CNPV) Pilot Program
In brief
The FDA has consolidated information on its website about the Commissioner's National Priority Voucher (CNPV) pilot program, which aims to shorten drug and biological product review times to 1-2 months. The program covers five national priority areas: public health crisis response, breakthrough innovative therapies, major unmet medical needs, onshoring of production and access, and uses a multidisciplinary collaborative review mechanism. The page also lists multiple products approved through the program between October 2025 and October 2026.
Why it matters
The official FDA page documents the CNPV pilot's five priority areas, review process, and approval list as a primary reference.
Source: U.S. FDA